Abstract
A worldwide adverse drug event monitoring and management system is described. Two subsidiaries encompassing over two dozen regional offices are linked by a FAX network. A common format is used for central collection and distribution of information. Each regional office reformats information to comply with regulatory reporting requirements. Surveillance methods are described, coordination problems are outlined, and sources of bias in assessing incidence changes are discussed
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
